Pacira Pharma (PCRX) Receives FDA Approval for Additional EXPAREL Manufacturing Suite
Tweet Send to a Friend
Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX announced that the U.S. Food and Drug Administration (FDA) approved an additional bulk manufacturing suite ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE